CBD

Yooma Wellness Announces Launch of MYO Plant Nutrition in Boots Stores Across the UK

Retrieved on: 
Monday, January 17, 2022 - 11:55am

The listing includes MYOs Plant Proteins in 838 stores, branched-chain amino acids (BCAA) and essential amino acids (EAA) in up to 574 stores, and functional sprays in 522 stores.

Key Points: 
  • The listing includes MYOs Plant Proteins in 838 stores, branched-chain amino acids (BCAA) and essential amino acids (EAA) in up to 574 stores, and functional sprays in 522 stores.
  • MYO products are 100%-plant-based, use clean and innovative ingredients, and focus on the growing area of full-body plant-based wellness, which includes nutrition, the gut, brain, immunity and other key elements of wellness.
  • James Lawson Baker, Founder of MYO Plant Nutrition, commented: This is a major milestone for MYO and we are absolutely delighted to be partnering with Boots, the leading health and beauty retailer in the UK.
  • Jordan Greenberg, CEO of Yooma, said: MYO Plant Nutrition is an exceptional example of how Yoomas buy-and-build strategy creates shareholder value.

Cronos Group Provides Bi-Weekly MCTO Status Update

Retrieved on: 
Friday, January 14, 2022 - 9:15pm

TORONTO, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (Cronos Group or the Company) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 Management Cease Trade Orders (NP 12-203).

Key Points: 
  • TORONTO, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (Cronos Group or the Company) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 Management Cease Trade Orders (NP 12-203).
  • Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents.
  • Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development.
  • With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio.

Hometown Hero CBD Announces Product With CBDA and CBGA Is Underway

Retrieved on: 
Friday, January 14, 2022 - 6:03pm

AUSTIN, Texas, Jan. 14, 2022 /PRNewswire/ --Hometown Hero CBD, announces today that it is developing an edible with CBDA and CBGA as its primary cannabinoids.

Key Points: 
  • AUSTIN, Texas, Jan. 14, 2022 /PRNewswire/ --Hometown Hero CBD, announces today that it is developing an edible with CBDA and CBGA as its primary cannabinoids.
  • Recently, Hometown Hero CBD launched its Hybrid Live Rosin Gummies, the first product of its kind in the consumable hemp market.
  • As with all of its products, Hometown Hero CBD plans to donate a portion of proceeds from its CBDA and CBGA edibles to nonprofit organizations that help veterans in need.
  • "We're very excited to announce this upcoming CBDA and CBGA product," said Lewis Hamer, Vice President of Hometown Hero CBD.

Franklin Street Properties Corp. Declares Regular Quarterly Dividend and Introduces Property Disposition Guidance for Full-Year 2022

Retrieved on: 
Friday, January 14, 2022 - 2:17pm

At this time, FSP is also introducing property disposition guidance for full-year 2022 to be in the range of approximately $250 million to $350 million in aggregate gross proceeds.

Key Points: 
  • At this time, FSP is also introducing property disposition guidance for full-year 2022 to be in the range of approximately $250 million to $350 million in aggregate gross proceeds.
  • This guidance reflects our current expectations of economic and market conditions and is subject to change.
  • Todays news release, along with other news about Franklin Street Properties Corp., is available on the Internet at www.fspreit.com .
  • About Franklin Street Properties Corp.
    Franklin Street Properties Corp., based in Wakefield, Massachusetts, is focused on infill and central business district (CBD) office properties in the U.S. Sunbelt and Mountain West, as well as select opportunistic markets.

Extract Labs Launches Immune Support Tincture, First CBGa Product to Hit the Consumer Market

Retrieved on: 
Friday, January 14, 2022 - 1:00pm

LAFAYETTE, Colo., Jan. 14, 2022 /PRNewswire/ -- Extract Labs ,a leading full-service CBD extraction laboratory and retailer, today announced the launch of its 2,000mg full-spectrum Immune Support CBGa CBDa Tincture , a 1:1:1:1 500mg CBGa, CBDa, CBG and CBD tincture blend that is the first-of-its-kind to hit the consumer market.

Key Points: 
  • LAFAYETTE, Colo., Jan. 14, 2022 /PRNewswire/ -- Extract Labs ,a leading full-service CBD extraction laboratory and retailer, today announced the launch of its 2,000mg full-spectrum Immune Support CBGa CBDa Tincture , a 1:1:1:1 500mg CBGa, CBDa, CBG and CBD tincture blend that is the first-of-its-kind to hit the consumer market.
  • Extract Labs' Immune Support Tincture is the first consumer product to contain CBGa.
  • Extracted from Colorado-grown hemp, this the Immune Support Tincture will come in a 30ml bottle containing 2,000mg full-spectrum cannabinoids.
  • Extract Labs new Immune Support Tincture is available at an introductory offer of $90 (MRSP $120) .

Avicanna Enters Master Supply Agreement with Chilean Pharmaceutical Pioneer Knop Laboratorios S.A.

Retrieved on: 
Friday, January 14, 2022 - 12:30pm

TORONTO, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that through its majority owned subsidiary Santa Marta Golden Hemp (“SMGH”) the company has entered into a Master Supply Agreement with established Chilean pharmaceutical company Knop Laboratorios S.A. (“Knop”) to supply a range of cannabinoid-based active pharmaceutical ingredients (“API”) for the manufacturing, and commercialization of proprietary cannabinoid-based pharmaceutical products in Latin America.

Key Points: 
  • Knop Laboratorios S.A. is a Chilean pharmaceutical company and pioneer in herbal medicine with more than 90 years of experience in the field and active presence in several Latin American countries including Chile, Ecuador, Colombia, Bolivia, Paraguay, and Peru.
  • With a GMP certified plant located in Quilpu, Chile, Knop Laboratorios serves its markets with high-quality pharmaceutical products.
  • In 2021, Knop opened the first R&D Center in Chile for phytomedicines and active ingredients of natural origin.
  • Knop is carrying out various Clinical Studies for their cannabinoid-based products, with authorization from the appropriate health authorities.

High Tide Opens New Canna Cabana Location in Regina, and Provides Timing for Release of Fourth Quarter and Fiscal Year 2021 Financial Results and Webcast

Retrieved on: 
Friday, January 14, 2022 - 11:02am

This opening represents High Tides 107thbranded retail location across Canada, and 7th in Saskatchewan, selling recreational cannabis products and consumption accessories.

Key Points: 
  • This opening represents High Tides 107thbranded retail location across Canada, and 7th in Saskatchewan, selling recreational cannabis products and consumption accessories.
  • I look forward to sharing more information about its progress, as well as our fourth quarter 2021 results, on January 27th, added Mr. Grover.
  • High Tides fourth quarter and fiscal year 2021 financial and operational results will be available on SEDAR and on the Companys website at www.hightideinc.com/invest .
  • The webcast and conference call will discuss High Tides fourth quarter and fiscal year 2021 financial and operational results, as well as the Companys plans for 2022.

High Tide Opens New Canna Cabana Location in Regina, and Provides Timing for Release of Fourth Quarter and Fiscal Year 2021 Financial Results and Webcast

Retrieved on: 
Friday, January 14, 2022 - 11:00am

This opening represents High Tide's 107thbranded retail location across Canada, and 7th in Saskatchewan, selling recreational cannabis products and consumption accessories.

Key Points: 
  • This opening represents High Tide's 107thbranded retail location across Canada, and 7th in Saskatchewan, selling recreational cannabis products and consumption accessories.
  • I look forward to sharing more information about its progress, as well as our fourth quarter 2021 results, on January 27th," added Mr. Grover.
  • High Tide's fourth quarter and fiscal year 2021 financial and operational results will be available on SEDAR and on the Company's website at www.hightideinc.com/invest .
  • The webcast and conference call will discuss High Tide's fourth quarter and fiscal year 2021 financial and operational results, as well as the Company's plans for 2022.

CBD Fights Covid, The Hemp Collect Suggests Live Resin

Retrieved on: 
Thursday, January 13, 2022 - 10:32pm

Portland, OR, Jan. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- In a newly published study, researchers have found that cannabidiol and cannabigerol, commonly known as CBD and CBG, may limit the reproduction and spread of the COVID-19 virus. This is exciting news as in spite of the release of vaccines the virus has continued to spread. The Hemp Collect warns industry businesses to share the news cautiously as to avoid penalization from the FDA for false claims and urges consumers purchasing CBD to understand the factors impacting the efficacy of CBD products for this use.

Key Points: 
  • Hemp compounds, CBDa and CBGa positively impact SARS-CoV-2 infections but this is not the same as CBD and CBG warns The Hemp Collect.
  • The Hemp Collect warns industry businesses to share the news cautiously as to avoid penalization from the FDA for false claims and urges consumers purchasing CBD to understand the factors impacting the efficacy of CBD products for this use.
  • Ashley Dellinger of The Hemp Collect , a CBD Live Resin producer, notes, Its important to make the distinction that the study highlights CBDa and CBGa specifically.
  • This is very positive for the industry and society and we are excited for the news, Joel Thompson from The Hemp Collect states.

RESET Bioscience Debuts Bioavailable Pet CBD Drops

Retrieved on: 
Thursday, January 13, 2022 - 7:00pm

AUSTIN, Texas, Jan. 13, 2022 /PRNewswire/ --RESET Bioscience, an advanced wellness company that uses pharmaceutical grade ingredients and technologies, introduces Pet CBD Drops to their portfolio.

Key Points: 
  • AUSTIN, Texas, Jan. 13, 2022 /PRNewswire/ --RESET Bioscience, an advanced wellness company that uses pharmaceutical grade ingredients and technologies, introduces Pet CBD Drops to their portfolio.
  • Developed by leading Ph.D.scientists, RESET Pet CBD Drops are the world's first water-based, ingestible CBD for pets featuring Powered by Sant Delivery Technology for rapid, maximum absorption and are double-tested to human standards.
  • About RESET Pet CBD Drops:
    5 mg of Highly-Bioavailable CBD per 0.5 mL, 150 mg Per Bottle
    Hemp-Derived Cannabidiol (CBD) sourced from premium hemp cultivated in the USA.
  • For more information about RESET Pet CBD Drops, please visit RESETbioscience.com and follow on Instagram, TikTok and Facebook @RESETbioscience .